How to Use Primary Patient Samples in Preclinical Models to Improve Translational Relevance in Blood Cancer Research

Hematologic research faces critical challenges that hinder effective blood cancer treatments. One major issue is the use of traditional animal models, which often don't accurately reflect human disease, leading to misleading results and higher clinical trial failure rates. Additionally, blood cancer's complexity, with genetic diversity and changing tumor environments, poses significant obstacles to understanding the disease and finding key biomarkers. This comprehensive webinar will guide you through effective strategies to mitigate these challenges by leveraging Champions’ unparalleled bank of hematological models: • Model Selection: How do you find the most clinically relevant models? • Primary or Passaged Models: What gives you the most biologically relevant results? • Ex vivo or In vivo Modeling: What type of study best replicates the complex tumor environment? • Successful Applications: Case studies demonstrating how you can accelerate your research